HLA class I gene polymorphism in Iranian patients with Papillon-Lefevre Syndrome

Iranian Journal of Immunology

Volumn 4, Issue 4, 2007, Pages 241-245

  Farjadian, Shirin ^a,b   Kiyanimanesh, Nasrin ^a   Abbaszadegan, Abbas ^a   Lotfazar, Mehrdad ^c  

^a SHIRAZ UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b SHIRAZ UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^c Clinic of Periodontology   (Iran)

Author keywords

HLA class I; Iran; Papillon Lefevre Syndrome

Indexed keywords

HLA A ANTIGEN; HLA ANTIGEN CLASS 1; HLA B ANTIGEN; HLA C ANTIGEN;

ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; GENE FUNCTION; GENETIC POLYMORPHISM; GENETIC SUSCEPTIBILITY; GENOTYPE; HAPLOTYPE; HEREDITY; HUMAN; IMMUNE RESPONSE; IRAN; PALMOPLANTAR KERATODERMA; POLYMERASE CHAIN REACTION; SIBLING;

EID: 37249038898     PISSN: 17351383     EISSN: 1735367X     Source Type: Journal    
DOI: None     Document Type: Article

References (25)

1. Hart TC, Shapira L. Papillon-Lefèvre syndrome. Periodontol 2000. 1994; 6:88-100.
2. Bergman R, Friedman-Birnbaum R. Papillon-Lefèvre syndrome: a study of the long-term clinical course of recurrent pyogenic infections and the effects of etretinate treatment. Br J Dermatol. 1988; 119:731-6.
3. Haneke E, Hornstein OP, Lex C. Increased susceptibility to infections in the Papillon-Lefèvre syndrome. Dermatologica. 1975; 150:283-6.
4. Van Dyke TE, Sheilesh D. Risk factors for periodontitis. J Int Acad Periodontol. 2005;7:3-7.
5. Hart TC. Genetic risk factors for early-onset periodontitis. J Periodontol. 1996; 67:355-66.
6. Fischer J, Blanchet-Bardon C, Prud'homme JF, Pavek S, Steijlen PM, Dubertret L et al. Mapping of Papillon-Lefèvre syn-drome to the chromosome 11q14 region. Eur J Hum Genet. 1997; 5:156-60.
7. Laass MW, Hennies HC, Preis S, Stevens HP, Jung M, Leigh IM et al. Localisation of a gene for Papillon-Lefèvre syndrome to chromosome 11q14-q21 by homozygosity mapping. Hum Genet. 1997; 101:376-82.
8. Pham CT, Ivanovich JL, Raptis SZ, Zehnbauer B, Ley TJ. Papillon-Lefèvre syndrome: correlating the molecular, cellular, and clinical consequences of cathepsin C/dipeptidyl peptidase I deficiency in humans. J Immunol. 2004; 173:7277-81.
9. Hart PS, Zhang Y, Firatli E, Uygur C, Lotfazar M, Michalec MD et al. Identification of cathepsin C mutations in ethnically diverse Papillon-Lefèvre syndrome patients. J Med Genet. 2000; 37:927-32.
10. Cury VF, Costa JE, Gomez RS, Boson WL, Loures CG, De ML. A novel mutation of the cathepsin C gene in Papillon-Lefèvre syndrome. J Periodontol. 2002; 73:307-12.
11. Van Steensel MA, Van Geel M, Steijlen PM. New syndrome of hypotrichosis, striate palmoplantar keratoderma, acro-osteolysis and periodontitis not due to mutations in cathepsin C. Br J Dermatol. 2002; 147:575-81.
12. Zhang Y, Lundgren T, Renvert S, Tatakis DN, Firatli E, Uygur C et al. Evidence of a founder effect for four cathepsin C gene mutations in Papillon-Lefèvre syndrome patients. J Med Genet. 2001;38:96-101.
13. Lie BA, Thorsby E. Several genes in the extended human MHC contribute to predisposition to autoimmune diseases. Curr Opin Immunol. 2005;17:526-31.
14. Shiina T, Inoko H, Kulski JK. An update of the HLA genomic region, locus information and disease associations: 2004. Tissue Antigens. 2004;64:631-49.
15. Roshna T, Thomas R, Nandakumar K, Banerjee MA. Case-control study on the association of human leukocyte antigen-A*9 and B*15 alleles with generalized aggressive periodontitis in an Indian population. J Periodonto. 2006; 77:1954-63.
16. Shapira L, Eizenberg S, Sela MN, Soskolne A, Brautbar H. HLA-A9 and B15 are associated with the generalized form, but not the localized form, of early-onset periodontal diseases. J Periodonto. 1994; 65:219-23.
17. Stein J, Reichert S, Gautsch A, Machulla HK. Are there HLA combinations typical supporting for or making resistant against aggressive and/or chronic periodontitis? J Periodontal Res. 2003;38:508-17.
18. Machulla HK, Stein J, Gautsch A, Langner J, Schaller HG, Reichert S. HLA-A, B, Cw, DRB1, DRB3/4/5, DQB1 in German patients suffering from rapidly progressive periodontitis (RPP) and adult periodontitis (AP). J Clin Periodontol. 2002;29:573-9.
19. Kastelan M, Gruber F, Cecuk E, Kerhin-Brkljacic V, Brkljacic-Surkalovic L, Kastelan A. Analysis of HLA antigens in Croatian patients with psoriasis. Acta Derm Venereol Suppl (Stockh). 2000;211:12-3.
20. Nanda A, Al-Fouzan AS, El-Kashlan M, Al-Sweih N, Al-Muzairai I. Salient features and HLA markers of childhood psoriasis in Kuwait. Clin Exp Dermatol. 2000;25:147-51.
21. Atasoy M, Pirim I, Bayrak OF, Ozdemir S, Ikbal M, Erdem T et al. Associations of HLA class I and class II alleles with psoriasis vulgaris in Turkish population. Influence of type I and II psoriasis. Saudi Med J 2006; 27: 373-6.
22. Gudjonsson JE, Karason A, Runarsdottir EH, Antonsdottir AA, Hauksson VB, Jonsson HH et al. Distinct clinical differences between HLA-Cw*0602 positive and negative psoriasis patients-an analysis of 1019 HLA-C and HLA-B-typed patients. J Invest Dermatol. 2006; 126:740-5.
23. Bahram S. MIC genes: from genetics to biology. Adv Immunol. 2000; 76:1-60.
24. Suzuki Y, Hamamoto Y, Ogasawara Y, Ishikawa K, Yoshikawa Y, Sasazuki T et al. Genetic polymorphisms of killer cell immunoglobulin-like receptors are associated with susceptibility to psoriasis vulgaris. J Invest Dermatol. 2004; 122:1133-6.
25. Campillo JA, Martínez-Escribano JA, Moya-Quiles MR, Marín LA, Muro M, Guerra N et al. Natural killer receptors on CD8 T cells and natural killer cells from different HLA-C phenotypes in melanoma patients. Clin Cancer Res. 2006; 12:4822-31.